Phosphorylation of NBR1 by GSK3 modulates protein aggregation

References

• Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science 2002; 296:1991 - 5; http://dx.doi.org/10.1126/science.1067122; PMID: 12065827
   PubMed Web of Science ®Google Scholar
• Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O’Kane CJ, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004; 36:585 - 95; http://dx.doi.org/10.1038/ng1362; PMID: 15146184
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Lucas JJ, Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease. Cell 2000; 101:57 - 66; http://dx.doi.org/10.1016/S0092-8674(00)80623-6; PMID: 10778856
   PubMed Web of Science ®Google Scholar
• Zu T, Duvick LA, Kaytor MD, Berlinger MS, Zoghbi HY, Clark HB, Orr HT. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J Neurosci 2004; 24:8853 - 61; http://dx.doi.org/10.1523/JNEUROSCI.2978-04.2004; PMID: 15470152
   PubMed Web of Science ®Google Scholar
• Holmberg CI, Staniszewski KE, Mensah KN, Matouschek A, Morimoto RI. Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J 2004; 23:4307 - 18; http://dx.doi.org/10.1038/sj.emboj.7600426; PMID: 15470501
   PubMed Web of Science ®Google Scholar
• Venkatraman P, Wetzel R, Tanaka M, Nukina N, Goldberg AL. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol Cell 2004; 14:95 - 104; http://dx.doi.org/10.1016/S1097-2765(04)00151-0; PMID: 15068806
   PubMed Web of Science ®Google Scholar
• Filimonenko M, Isakson P, Finley KD, Anderson M, Jeong H, Melia TJ, Bartlett BJ, Myers KM, Birkeland HC, Lamark T, et al. The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol Cell 2010; 38:265 - 79; http://dx.doi.org/10.1016/j.molcel.2010.04.007; PMID: 20417604
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12:814 - 22; http://dx.doi.org/10.1038/ncb0910-814; PMID: 20811353
   PubMed Web of Science ®Google Scholar
• Kirkin V, Lamark T, Sou YS, Bjørkøy G, Nunn JL, Bruun JA, Shvets E, McEwan DG, Clausen TH, Wild P, et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 2009; 33:505 - 16; http://dx.doi.org/10.1016/j.molcel.2009.01.020; PMID: 19250911
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkøy G, Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007; 282:24131 - 45; http://dx.doi.org/10.1074/jbc.M702824200; PMID: 17580304
   PubMed Web of Science ®Google Scholar
• Waters S, Marchbank K, Solomon E, Whitehouse C, Gautel M. Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover. FEBS Lett 2009; 583:1846 - 52; http://dx.doi.org/10.1016/j.febslet.2009.04.049; PMID: 19427866
   PubMed Web of Science ®Google Scholar
• Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 2011; 44:279 - 89; http://dx.doi.org/10.1016/j.molcel.2011.07.039; PMID: 22017874
   PubMed Web of Science ®Google Scholar
• Gal J, Ström AL, Kilty R, Zhang F, Zhu H. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem 2007; 282:11068 - 77; http://dx.doi.org/10.1074/jbc.M608787200; PMID: 17296612
   PubMed Web of Science ®Google Scholar
• Odagiri S, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy. Acta Neuropathol 2012; 124:173 - 86; http://dx.doi.org/10.1007/s00401-012-0975-7; PMID: 22484440
   PubMed Web of Science ®Google Scholar
• D’Agostino C, Nogalska A, Cacciottolo M, Engel WK, Askanas V. Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis. Acta Neuropathol 2011; 122:627 - 36; http://dx.doi.org/10.1007/s00401-011-0874-3; PMID: 21935636
   PubMed Web of Science ®Google Scholar
• Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002; 160:255 - 63; http://dx.doi.org/10.1016/S0002-9440(10)64369-6; PMID: 11786419
   PubMed Web of Science ®Google Scholar
• Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011; 333:228 - 33; http://dx.doi.org/10.1126/science.1205405; PMID: 21617041
   PubMed Web of Science ®Google Scholar
• Deosaran E, Larsen KB, Hua R, Sargent G, Wang Y, Kim S, Lamark T, Jauregui M, Law K, Lippincott-Schwartz J, et al. NBR1 acts as an autophagy receptor for peroxisomes. J Cell Sci 2013; 126:939 - 52; http://dx.doi.org/10.1242/jcs.114819; PMID: 23239026
   PubMed Web of Science ®Google Scholar
• Kuo TC, Chen CT, Baron D, Onder TT, Loewer S, Almeida S, Weismann CM, Xu P, Houghton JM, Gao FB, et al. Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat Cell Biol 2011; 13:1214 - 23; http://dx.doi.org/10.1038/ncb2332; PMID: 21909099
   PubMed Web of Science ®Google Scholar
• Mardakheh FK, Yekezare M, Machesky LM, Heath JK. Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling. J Cell Biol 2009; 187:265 - 77; http://dx.doi.org/10.1083/jcb.200905118; PMID: 19822672
   PubMed Web of Science ®Google Scholar
• Mardakheh FK, Auciello G, Dafforn TR, Rappoport JZ, Heath JK. Nbr1 is a novel inhibitor of ligand-mediated receptor tyrosine kinase degradation. Mol Cell Biol 2010; 30:5672 - 85; http://dx.doi.org/10.1128/MCB.00878-10; PMID: 20937771
   PubMed Web of Science ®Google Scholar
• Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B, et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005; 308:1599 - 603; http://dx.doi.org/10.1126/science.1110463; PMID: 15802564
   PubMed Web of Science ®Google Scholar
• Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378:785 - 9; http://dx.doi.org/10.1038/378785a0; PMID: 8524413
   PubMed Web of Science ®Google Scholar
• Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004; 29:95 - 102; http://dx.doi.org/10.1016/j.tibs.2003.12.004; PMID: 15102436
   PubMed Web of Science ®Google Scholar
• Wills J, Jones J, Haggerty T, Duka V, Joyce JN, Sidhu A. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson’s disease brains with and without dementia. Exp Neurol 2010; 225:210 - 8; http://dx.doi.org/10.1016/j.expneurol.2010.06.017; PMID: 20599975
   PubMed Web of Science ®Google Scholar
• Carmichael J, Sugars KL, Bao YP, Rubinsztein DC. Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington’s disease mutation. J Biol Chem 2002; 277:33791 - 8; http://dx.doi.org/10.1074/jbc.M204861200; PMID: 12097329
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001; 65:391 - 426; http://dx.doi.org/10.1016/S0301-0082(01)00011-9; PMID: 11527574
   PubMed Web of Science ®Google Scholar
• Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005; 170:1101 - 11; http://dx.doi.org/10.1083/jcb.200504035; PMID: 16186256
   PubMed Web of Science ®Google Scholar
• Pilot-Storck F, Chopin E, Rual JF, Baudot A, Dobrokhotov P, Robinson-Rechavi M, Brun C, Cusick ME, Hill DE, Schaeffer L, et al. Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor. Mol Cell Proteomics 2010; 9:1578 - 93; http://dx.doi.org/10.1074/mcp.M900568-MCP200; PMID: 20368287
   PubMed Web of Science ®Google Scholar
• Kunick C, Lauenroth K, Leost M, Meijer L, Lemcke T. 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta. Bioorg Med Chem Lett 2004; 14:413 - 6; http://dx.doi.org/10.1016/j.bmcl.2003.10.062; PMID: 14698171
   PubMed Web of Science ®Google Scholar
• Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol 2001; 2:769 - 76; http://dx.doi.org/10.1038/35096075; PMID: 11584304
   PubMed Web of Science ®Google Scholar
• Frame S, Cohen P, Biondi RM. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 2001; 7:1321 - 7; http://dx.doi.org/10.1016/S1097-2765(01)00253-2; PMID: 11430833
   PubMed Web of Science ®Google Scholar
• Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 2002; 34:509 - 19; http://dx.doi.org/10.1016/S0896-6273(02)00706-7; PMID: 12062036
   PubMed Web of Science ®Google Scholar
• Lelouard H, Ferrand V, Marguet D, Bania J, Camosseto V, David A, Gatti E, Pierre P. Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J Cell Biol 2004; 164:667 - 75; http://dx.doi.org/10.1083/jcb.200312073; PMID: 14981091
   PubMed Web of Science ®Google Scholar
• Selcen D. Myofibrillar myopathies. Neuromuscul Disord 2011; 21:161 - 71; http://dx.doi.org/10.1016/j.nmd.2010.12.007; PMID: 21256014
   PubMed Web of Science ®Google Scholar
• Olivé M, van Leeuwen FW, Janué A, Moreno D, Torrejón-Escribano B, Ferrer I. Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies. Neuropathol Appl Neurobiol 2008; 34:76 - 87; PMID: 17931355
   PubMed Web of Science ®Google Scholar
• Dalakas MC, Dagvadorj A, Goudeau B, Park KY, Takeda K, Simon-Casteras M, Vasconcelos O, Sambuughin N, Shatunov A, Nagle JW, et al. Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations. Neuromuscul Disord 2003; 13:252 - 8; http://dx.doi.org/10.1016/s0960-8966(02)00271-7; PMID: 12609507
   PubMed Web of Science ®Google Scholar
• Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S, Sandri M. Autophagy is required to maintain muscle mass. Cell Metab 2009; 10:507 - 15; http://dx.doi.org/10.1016/j.cmet.2009.10.008; PMID: 19945408
   PubMed Web of Science ®Google Scholar
• Askanas V, Engel WK. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau. Presse Med 2011; 40:e219 - 35; http://dx.doi.org/10.1016/j.lpm.2010.11.024; PMID: 21392932
   PubMedGoogle Scholar
• Morosetti R, Broccolini A, Sancricca C, Gliubizzi C, Gidaro T, Tonali PA, Ricci E, Mirabella M. Increased aging in primary muscle cultures of sporadic inclusion-body myositis. Neurobiol Aging 2010; 31:1205 - 14; http://dx.doi.org/10.1016/j.neurobiolaging.2008.08.011; PMID: 18823681
   PubMed Web of Science ®Google Scholar
• Terracciano C, Nogalska A, Engel WK, Askanas V. In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis. J Neurochem 2010; 112:389 - 96; http://dx.doi.org/10.1111/j.1471-4159.2009.06461.x; PMID: 19878439
   PubMed Web of Science ®Google Scholar
• Lei P, Ayton S, Bush AI, Adlard PA. GSK-3 in Neurodegenerative Diseases. Int J Alzheimers Dis 2011; 2011:189246; http://dx.doi.org/10.4061/2011/189246; PMID: 21629738
   PubMedGoogle Scholar
• Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20:1981 - 91; http://dx.doi.org/10.1091/mbc.E08-12-1248; PMID: 19211835
   PubMed Web of Science ®Google Scholar
• Lin SY, Li TY, Liu Q, Zhang C, Li X, Chen Y, Zhang SM, Lian G, Liu Q, Ruan K, et al. GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy. Science 2012; 336:477 - 81; http://dx.doi.org/10.1126/science.1217032; PMID: 22539723
   PubMed Web of Science ®Google Scholar
• Ohlsson M, Hedberg C, Brådvik B, Lindberg C, Tajsharghi H, Danielsson O, Melberg A, Udd B, Martinsson T, Oldfors A. Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. Brain 2012; 135:1682 - 94; http://dx.doi.org/10.1093/brain/aws103; PMID: 22577218
   PubMed Web of Science ®Google Scholar
• Pfeffer G, Barresi R, Wilson IJ, Hardy SA, Griffin H, Hudson J, Elliott HR, Ramesh AV, Radunovic A, Winer JB, et al. Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry 2014; 85:331 - 8; http://dx.doi.org/10.1136/jnnp-2012-304728; PMID: 23486992
   PubMed Web of Science ®Google Scholar
• Kramer T, Schmidt B, Lo Monte F. Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer’s Disease Models. Int J Alzheimers Dis 2012; 2012:381029; http://dx.doi.org/10.1155/2012/381029; PMID: 22888461
   PubMedGoogle Scholar
• MacAulay K, Doble BW, Patel S, Hansotia T, Sinclair EM, Drucker DJ, Nagy A, Woodgett JR. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab 2007; 6:329 - 37; http://dx.doi.org/10.1016/j.cmet.2007.08.013; PMID: 17908561
   PubMed Web of Science ®Google Scholar
• Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117:399 - 412; http://dx.doi.org/10.1016/S0092-8674(04)00400-3; PMID: 15109499
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9:671 - 5; http://dx.doi.org/10.1038/nmeth.2089; PMID: 22930834
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885 - 9; http://dx.doi.org/10.1038/nature04724; PMID: 16625204
   PubMed Web of Science ®Google Scholar